TNF-Related Apoptosis-Inducing Ligand Receptor 1 in Patients With Ankylosing Spondylitis.


Karadag D. , Tekeoglu S., Yazici A. , Isik O., Eraldemir F. C. , Cefle A.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, vol.26, no.6, pp.242-247, 2020 (Journal Indexed in SCI Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 26 Issue: 6
  • Publication Date: 2020
  • Doi Number: 10.1097/rhu.0000000000001050
  • Title of Journal : Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases
  • Page Numbers: pp.242-247

Abstract

Objectives: Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) belongs to the tumor necrosis factor (TNF) superfamily and is reported to play a role in autoimmune diseases. In this study, we aimed to measure serum TRAIL receptor 1 (TRAIL-R1) concentration and assess any phenotypic relationship in patients with ankylosing spondylitis (AS).